KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Twist Bioscience (TWST) Cash from Investing Activities: 2017-2025

Historic Cash from Investing Activities for Twist Bioscience (TWST) over the last 8 years, with Sep 2025 value amounting to -$12.4 million.

  • Twist Bioscience's Cash from Investing Activities fell 865.21% to -$12.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$24.8 million, marking a year-over-year decrease of 706.32%. This contributed to the annual value of -$24.8 million for FY2025, which is 706.32% down from last year.
  • Per Twist Bioscience's latest filing, its Cash from Investing Activities stood at -$12.4 million for Q3 2025, which was down 31.99% from -$9.4 million recorded in Q2 2025.
  • Over the past 5 years, Twist Bioscience's Cash from Investing Activities peaked at $104.6 million during Q2 2021, and registered a low of -$226.6 million during Q4 2021.
  • Over the past 3 years, Twist Bioscience's median Cash from Investing Activities value was -$1.4 million (recorded in 2025), while the average stood at $2.7 million.
  • Per our database at Business Quant, Twist Bioscience's Cash from Investing Activities soared by 409.61% in 2023 and then slumped by 1,221.66% in 2025.
  • Quarterly analysis of 5 years shows Twist Bioscience's Cash from Investing Activities stood at -$226.6 million in 2021, then skyrocketed by 96.92% to -$7.0 million in 2022, then skyrocketed by 159.75% to $4.2 million in 2023, then plummeted by 136.88% to -$1.5 million in 2024, then plummeted by 865.21% to -$12.4 million in 2025.
  • Its Cash from Investing Activities was -$12.4 million in Q3 2025, compared to -$9.4 million in Q2 2025 and -$1.4 million in Q1 2025.